# Combined Analysis of the Transcriptome and Metabolome at Different Tissue Glycogen Levels in Yili Horses

**Authors:** Xueyan Li, Shuman Qian, Liping Yang, Xixi Yang, Xiaokang Chang, Yaqi Zeng, Jun Meng

PMC · DOI: 10.3390/ani16040662 · Animals : an Open Access Journal from MDPI · 2026-02-19

## TL;DR

This study explores how genes and metabolites contribute to glycogen metabolism in different tissues of Yili horses, focusing on liver and muscle tissues.

## Contribution

The study provides a multi-omics analysis of glycogen metabolism in Yili horses, revealing key genes and metabolites involved in tissue-specific regulation.

## Key findings

- Differentially expressed genes in liver and muscle tissues are primarily linked to glycolysis and fructose/mannose metabolism.
- Key genes like ACO1, ACLY, PCK2, and FBP1, along with metabolites like leucine and tyrosine, are associated with glycogen synthesis in the liver.
- The study identifies regulatory differences in glycogen metabolism between liver and muscle tissues in Yili horses.

## Abstract

This study systematically analyzed the glycogen content across various tissues in Yili horses, conducting transcriptomic and broadly targeted metabolomics investigations on the visceral (liver) and muscle (gluteus medius) tissues, which exhibit the highest glycogen concentrations. A total of 1485 metabolites and 7366 mRNAs were identified with differential expression. Notably, these differentially expressed genes are predominantly involved in glycolysis and the metabolism of fructose and mannose. Through a multi−omics joint analysis, the mechanisms underlying glycogen synthesis and accumulation in different tissues of Yili horses were explored at a deeper and broader level, providing a theoretical foundation for elucidating the genetic mechanisms of glycogen metabolism in this breed.

This study aimed to investigate the relationship between genes and metabolites involved in glycogen metabolism across different tissues of Yili mares using joint transcriptomic and metabolomic analyses. Glycogen content was measured in various tissues (pincer, trapezius, latissimus dorsi, gluteus medius, semitendinosus, external abdominal obliques, liver, and heart) from seven Yili mares. The liver, as the visceral tissue with the highest glycogen content, and the gluteus medius, as the muscle with the highest glycogen content, were selected for transcriptomic sequencing and metabolomic analysis. KEGG pathway analysis of differentially expressed genes and metabolites in the liver and the gluteus medius revealed several key pathways associated with glycogen metabolism, including pentose and glucuronic acid interconversion, glycolysis/gluconeogenesis, the TCA cycle, fructose and mannose metabolism, and the pentose phosphate pathway. The gluteus medius tissue exhibited differential expression of 1485 metabolites and 7366 genes compared to the liver, with correlation coefficients between some genes and metabolites in the aforementioned pathways exceeding 0.8. This study highlights the regulatory differences in glycogen synthesis between liver and muscle tissues in Yili horses from multiple perspectives. Notably, genes such as ACO1, ACLY, PCK2, and FBP1, along with metabolites like leucine, tyrosine, and valine, play significant roles in regulating glycogen synthesis in the liver. It is hypothesized that these genes and metabolites contribute to the observed differences in energy metabolism between liver and muscle tissues in Yili horses; however, further in vivo and in vitro experiments are needed to validate this hypothesis.

## Linked entities

- **Genes:** ACO1 (aconitase 1) [NCBI Gene 48], ACLY (ATP citrate lyase) [NCBI Gene 47], PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial) [NCBI Gene 5106], FBP1 (fructose-bisphosphatase 1) [NCBI Gene 2203]
- **Chemicals:** leucine (PubChem CID 857), tyrosine (PubChem CID 1153), valine (PubChem CID 1182)

## Full-text entities

- **Genes:** ALDOC [NCBI Gene 100059231], HK1 [NCBI Gene 100072687], Insulin [NCBI Gene 100060077], VIP [NCBI Gene 100060155], PCK2 [NCBI Gene 100054903], PPP1R3A [NCBI Gene 100055851], citrate synthase [NCBI Gene 100052279], Muscle-type phosphofructokinase [NCBI Gene 100034116], INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ALDOB (aldolase, fructose-bisphosphate B) [NCBI Gene 229] {aka ALDB, ALDO2}, ALDOB [NCBI Gene 100054480], ALDOA [NCBI Gene 100066121], PCK1 [NCBI Gene 100055710], HK3 [NCBI Gene 100068725], ACLY [NCBI Gene 100053195], G6PC1 (glucose-6-phosphatase catalytic subunit 1) [NCBI Gene 2538] {aka G6PC, G6PT, G6Pase, GSD1, GSD1a}, GAPDH [NCBI Gene 100033897], HK2 [NCBI Gene 100009677], GYS [NCBI Gene 100054723], ACO1 [NCBI Gene 100067866], PGM2 [NCBI Gene 100064893], ENO3 (enolase 3) [NCBI Gene 2027] {aka GSD13, MSE}, ALDOA (aldolase, fructose-bisphosphate A) [NCBI Gene 226] {aka ALDA, GSD12, HEL-S-87p}, FBP1 [NCBI Gene 100063910], GYS2 [NCBI Gene 100064264], ALDOC (aldolase, fructose-bisphosphate C) [NCBI Gene 230] {aka ALDC}, PCK1 (phosphoenolpyruvate carboxykinase 1) [NCBI Gene 5105] {aka PCKDC, PEPCK-C, PEPCK1, PEPCKC}, PGK1 (phosphoglycerate kinase 1) [NCBI Gene 5230] {aka HEL-S-68p, MIG10, PGKA}, Glut4 [NCBI Gene 100033939]
- **Diseases:** injury to (MESH:D014947), dehydrated (MESH:D003681), fatigue (MESH:D005221)
- **Chemicals:** mannose (MESH:D008358), P400 (MESH:C110824), hypotaurine (MESH:C003949), methanol (MESH:D000432), amino sugar (MESH:D000606), cutin (MESH:C000521), pyruvate (MESH:D019289), keto acids (MESH:D007651), FC (-), glucuronic acid (MESH:D020723), ammonia (MESH:D000641), fructose-1,6-bisphosphate (MESH:C029063), inorganic phosphate (MESH:D010710), oligosaccharide (MESH:D009844), glycosaminoglycan (MESH:D006025), fructose-6-phosphate (MESH:C027618), sugars (MESH:D000073893), nitrogen (MESH:D009584), UDP-glucose (MESH:D014532), amino acids (MESH:D000596), fumaric acid (MESH:C032005), G6P (MESH:D019298), isocitric acid (MESH:C034219), OAA (MESH:D062907), fatty acid (MESH:D005227), pentose phosphate (MESH:D010428), carbohydrate (MESH:D002241), glyceraldehyde-3-phosphate (MESH:D005986), aconitate (MESH:D000156), alanine (MESH:D000409), TCA (MESH:D014233), carbon (MESH:D002244), propanoate (MESH:D011422), glucose-1-phosphate (MESH:C031590), starch (MESH:D013213), wax (MESH:D014885), acetonitrile (MESH:C032159), TCA (MESH:D014238), L-valine (MESH:D014633), glutamine (MESH:D005973), carbon dioxide (MESH:D002245), citrate (MESH:D019343), glutathione (MESH:D005978), L-tyrosine (MESH:D014443), water (MESH:D014867), L-leucine (MESH:D007930), fructose (MESH:D005632), Trizol (MESH:C411644), Glycogen (MESH:D006003), sucrose (MESH:D013395), acetyl-CoA (MESH:D000105), Lipid (MESH:D008055), ammonium acetate (MESH:C018824), dihydroxyacetone phosphate (MESH:D004099), glucosinolate (MESH:D005961), L-tryptophan (MESH:D014364), sphingolipid (MESH:D013107), Pentose (MESH:D010429), blood glucose (MESH:D001786), flavonoid (MESH:D005419)
- **Species:** Mycobacterium phage Ares (no rank) [taxon 1089112], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Equus caballus (domestic horse, species) [taxon 9796], Bos taurus (bovine, species) [taxon 9913]
- **Mutations:** G6P, G20211026S

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937391/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937391/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937391/full.md

---
Source: https://tomesphere.com/paper/PMC12937391